COMMUNIQUÉS West-GlobeNewswire

The Ensign Group Grows Operations in Colorado
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Increases Operations in Arizona
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Adds Real Estate and Operations in Kansas
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Alberta Cancer Foundation launches 'The Time Store' campaign to bring more moments to Albertans facing cancer
02/12/2025
Province-wide campaign asks Albertans to give more meaningful moments for people like patient Colin Dalziel EDMONTON, Alberta, Dec. 02, 2025 (GLOBE NEWSWIRE) -- This Giving Tuesday and throughout the holiday season, [...]
ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise
02/12/2025
Expert retina and uveitis specialists will help support the growth and innovation of ANI’s ophthalmology and retina franchise for a meaningful impact on patients PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- ANI [...]
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
02/12/2025
BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it [...]
Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook
02/12/2025
VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) is pleased to provide a corporate update following its recently released Q3 financial results and [...]
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
02/12/2025
Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a single 180mg dose of Briquilimab in the ETESIAN Study Preliminary data from ETESIAN study [...]
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
02/12/2025
NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need, today announced the [...]
Comanche Biopharma Appoints Richard Colvin, MD, PhD as Global Head of R&D and John McHutchison, AO, MD as Chairman and Director of Comanche Biopharma Australia
02/12/2025
Deeply experienced industry leaders further strengthen Comanche’s leadership and expertise as it advances CBP-4888 as a potential global solution for sFlt1-mediated preterm preeclampsia CONCORD, Mass., Dec. 02, 2025 ( [...]
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
02/12/2025
Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment 1.5% mean weight change observed with Revita (n=17); [...]
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
02/12/2025
Extends cash runway through at least the first half of 2028 Led by healthcare-dedicated investors, including Vivo Capital, Janus Henderson Investors, Coastlands Capital, Columbia Threadneedle Investments, Adage Capital [...]
CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)
02/12/2025
1st of two presentations with results from Phase 2b study of neflamapimod at the 18 th Clinical Trials on Alzheimer's Disease (CTAD) Conference Data demonstrates neflamapimod treatment led to significant reductions in [...]
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
02/12/2025
– Study, Which Enrolled 27 Patients, Met Primary Endpoint with a Significant Reduction in Hearing Loss in 3-18 Year Old Patients who Received PEDMARK ® when Compared with Historically Reported Rates of Hearing Loss in [...]
Ventyx Provides Clinical and Corporate Updates
02/12/2025
Strengthening our Advisory Board with addition of Mark McKenna as Strategic Advisor and Peter Libby, MD as a Clinical Advisor Expanding the Phase 2 recurrent pericarditis study into Canada, EU and the UK to evaluate QD [...]
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)
02/12/2025
The point-of-care test delivers PCR-accurate results in just 15 minutes, enabling healthcare providers to act quickly and prevent severe complications and onward transmission. Detects and differentiates between three [...]
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion
02/12/2025
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion Schlieren (Zürich), Switzerland, December 2, 2025 – Kuros [...]
Tecan expands robotic workcell offering with acquisition of Wako Automation assets
02/12/2025
Männedorf, Switzerland, December 2, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced the acquisition of Wako Automation assets, including the flagship Director™ scheduling software and select hardware [...]
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
02/12/2025
COPENHAGEN, Denmark, December 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12 months. This [...]

Pages